
Danny Hong
Examiner (ID: 2374, Phone: (571)270-5107 , Office: P/3727 )
| Most Active Art Unit | 3727 |
| Art Unit(s) | 3723, 3727 |
| Total Applications | 485 |
| Issued Applications | 270 |
| Pending Applications | 0 |
| Abandoned Applications | 215 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7460832
[patent_doc_number] => 20040052861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Sol-gel derived bioactive glass polymer composite'
[patent_app_type] => new
[patent_app_number] => 10/616884
[patent_app_country] => US
[patent_app_date] => 2003-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 16264
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20040052861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10616884
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/616884 | Sol-gel derived bioactive glass polymer composite | Jul 9, 2003 | Issued |
Array
(
[id] => 7468863
[patent_doc_number] => 20040054001
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Fumaric acid derivatives as nf-kappab inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/250983
[patent_app_country] => US
[patent_app_date] => 2003-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4628
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20040054001.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250983
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250983 | Fumaric acid derivatives as nf-kappab inhibitors | Jul 9, 2003 | Abandoned |
Array
(
[id] => 714569
[patent_doc_number] => 07052710
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-30
[patent_title] => 'Polymer re-inforced anatomically accurate bioactive protheses'
[patent_app_type] => utility
[patent_app_number] => 10/615466
[patent_app_country] => US
[patent_app_date] => 2003-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2928
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/052/07052710.pdf
[firstpage_image] =>[orig_patent_app_number] => 10615466
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/615466 | Polymer re-inforced anatomically accurate bioactive protheses | Jul 7, 2003 | Issued |
Array
(
[id] => 7088573
[patent_doc_number] => 20050008685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Oral rehydration compositions containing liposomes'
[patent_app_type] => utility
[patent_app_number] => 10/614940
[patent_app_country] => US
[patent_app_date] => 2003-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4342
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20050008685.pdf
[firstpage_image] =>[orig_patent_app_number] => 10614940
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/614940 | Oral rehydration compositions containing liposomes | Jul 6, 2003 | Abandoned |
Array
(
[id] => 5693761
[patent_doc_number] => 20060153908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Spherical pellet formulations'
[patent_app_type] => utility
[patent_app_number] => 10/519018
[patent_app_country] => US
[patent_app_date] => 2003-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5002
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20060153908.pdf
[firstpage_image] =>[orig_patent_app_number] => 10519018
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/519018 | Spherical pellet formulations | Jun 24, 2003 | Abandoned |
Array
(
[id] => 7430107
[patent_doc_number] => 20040001876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-01
[patent_title] => 'Breeding method of female pig for propagation and feed for female pig for propagation'
[patent_app_type] => new
[patent_app_number] => 10/600709
[patent_app_country] => US
[patent_app_date] => 2003-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8893
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20040001876.pdf
[firstpage_image] =>[orig_patent_app_number] => 10600709
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/600709 | Breeding method of female pig for propagation and feed for female pig for propagation | Jun 22, 2003 | Abandoned |
Array
(
[id] => 7269477
[patent_doc_number] => 20040057995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Process for the production of rapidly disintegrating, solid pharmaceutical preparations'
[patent_app_type] => new
[patent_app_number] => 10/600409
[patent_app_country] => US
[patent_app_date] => 2003-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3819
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0057/20040057995.pdf
[firstpage_image] =>[orig_patent_app_number] => 10600409
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/600409 | Process for the production of rapidly disintegrating, solid pharmaceutical preparations | Jun 18, 2003 | Issued |
Array
(
[id] => 1163152
[patent_doc_number] => 06756057
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-29
[patent_title] => 'Amoxicillin and potassium clavulanate dosage form'
[patent_app_type] => B2
[patent_app_number] => 10/462066
[patent_app_country] => US
[patent_app_date] => 2003-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 9420
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/756/06756057.pdf
[firstpage_image] =>[orig_patent_app_number] => 10462066
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/462066 | Amoxicillin and potassium clavulanate dosage form | Jun 12, 2003 | Issued |
Array
(
[id] => 7390279
[patent_doc_number] => 20040037873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Norethindrone sustained release formulations and methods associated therewith'
[patent_app_type] => new
[patent_app_number] => 10/449861
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5956
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20040037873.pdf
[firstpage_image] =>[orig_patent_app_number] => 10449861
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/449861 | Norethindrone sustained release formulations and methods associated therewith | May 29, 2003 | Abandoned |
Array
(
[id] => 7168629
[patent_doc_number] => 20050202088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 10/516268
[patent_app_country] => US
[patent_app_date] => 2003-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3666
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202088.pdf
[firstpage_image] =>[orig_patent_app_number] => 10516268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/516268 | Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof | May 14, 2003 | Abandoned |
Array
(
[id] => 6821324
[patent_doc_number] => 20030219485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Oral osmotic controlled drug delivery system'
[patent_app_type] => new
[patent_app_number] => 10/437045
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5388
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219485.pdf
[firstpage_image] =>[orig_patent_app_number] => 10437045
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/437045 | Oral osmotic controlled drug delivery system | May 13, 2003 | Abandoned |
Array
(
[id] => 6663702
[patent_doc_number] => 20030203028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Multiplex drug delivery system suitable for oral administration'
[patent_app_type] => new
[patent_app_number] => 10/435013
[patent_app_country] => US
[patent_app_date] => 2003-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3388
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203028.pdf
[firstpage_image] =>[orig_patent_app_number] => 10435013
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/435013 | Multiplex drug delivery system suitable for oral administration | May 11, 2003 | Abandoned |
Array
(
[id] => 6825663
[patent_doc_number] => 20030236285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Stabilized pharmaceutical compositions containing benzimidazole compounds'
[patent_app_type] => new
[patent_app_number] => 10/431271
[patent_app_country] => US
[patent_app_date] => 2003-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5461
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20030236285.pdf
[firstpage_image] =>[orig_patent_app_number] => 10431271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/431271 | Stabilized pharmaceutical compositions containing benzimidazole compounds | May 6, 2003 | Abandoned |
Array
(
[id] => 7702662
[patent_doc_number] => 08088415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-03
[patent_title] => 'Diffusion-controlled dosage form and method of fabrication including three dimensional printing'
[patent_app_type] => utility
[patent_app_number] => 10/431353
[patent_app_country] => US
[patent_app_date] => 2003-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 17
[patent_no_of_words] => 17568
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/088/08088415.pdf
[firstpage_image] =>[orig_patent_app_number] => 10431353
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/431353 | Diffusion-controlled dosage form and method of fabrication including three dimensional printing | May 5, 2003 | Issued |
Array
(
[id] => 7136082
[patent_doc_number] => 20040043964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Cellulosic particle for pharmaceuticals preparation'
[patent_app_type] => new
[patent_app_number] => 10/415979
[patent_app_country] => US
[patent_app_date] => 2003-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14813
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20040043964.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415979
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415979 | Cellulosic particle for pharmaceuticals preparation | May 5, 2003 | Abandoned |
Array
(
[id] => 7316767
[patent_doc_number] => 20040224000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Implants for non-radioactive brachytherapy of hormonal-insensitive cancers'
[patent_app_type] => new
[patent_app_number] => 10/430132
[patent_app_country] => US
[patent_app_date] => 2003-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3363
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224000.pdf
[firstpage_image] =>[orig_patent_app_number] => 10430132
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/430132 | Implants for non-radioactive brachytherapy of hormonal-insensitive cancers | May 4, 2003 | Abandoned |
Array
(
[id] => 7004670
[patent_doc_number] => 20050169983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => 'Chewable soft capsule'
[patent_app_type] => utility
[patent_app_number] => 10/512318
[patent_app_country] => US
[patent_app_date] => 2003-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4374
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20050169983.pdf
[firstpage_image] =>[orig_patent_app_number] => 10512318
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/512318 | Chewable soft capsule | Apr 23, 2003 | Issued |
Array
(
[id] => 7295146
[patent_doc_number] => 20040213847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Delayed release pharmaceutical compositions containing proton pump inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/421229
[patent_app_country] => US
[patent_app_date] => 2003-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4105
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20040213847.pdf
[firstpage_image] =>[orig_patent_app_number] => 10421229
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/421229 | Delayed release pharmaceutical compositions containing proton pump inhibitors | Apr 22, 2003 | Abandoned |
Array
(
[id] => 421648
[patent_doc_number] => 07273619
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-25
[patent_title] => 'Transdermal composition of an antivomiting agent'
[patent_app_type] => utility
[patent_app_number] => 10/414827
[patent_app_country] => US
[patent_app_date] => 2003-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6004
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/273/07273619.pdf
[firstpage_image] =>[orig_patent_app_number] => 10414827
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/414827 | Transdermal composition of an antivomiting agent | Apr 14, 2003 | Issued |
Array
(
[id] => 5595835
[patent_doc_number] => 20060159751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Controlled release pharmaceutical compositions of carbidopa and levodopa'
[patent_app_type] => utility
[patent_app_number] => 10/510468
[patent_app_country] => US
[patent_app_date] => 2003-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3743
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20060159751.pdf
[firstpage_image] =>[orig_patent_app_number] => 10510468
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/510468 | Controlled release pharmaceutical compositions of carbidopa and levodopa | Apr 10, 2003 | Abandoned |